Pagliara, D., Merli, P., Galimard, J., Dalissier, A., Zubarovskaya, L., Rakhmanova, Z., Maschan, A., Shelikhova, L., Maschan, M., Vicent, M., Rihani, R., Fagioli, F., Benakli, M., Ghemlas, I., Biffi, A., Urtasun, A., Faraci, M., Kharya, G., Prete, A., Tintori, V., Kleinschmidt, K., Ansari, M., Peters, C., Corbacioglu, S., Bader, P., Kalwak, K., Locatelli, F. (2025). Comparison of outcomes in pediatric patients with acute leukemia undergoing allogeneic HLA-haploidentical hematopoietic stem cell transplantation (HSCT) after in vitro a/b T- and CD19-cell depletion or In Vivo administration of post-transplant cyclophosphamide: An EBMT pediatric working party study. Blood. https://doi.org/10.1182/blood-2025-515